-transparent.png){kind=logo}
Plasma transport of 99mTc-p-butyl-IDA was measured by four in vitro methods: trichloroacetic acid precipitation, electrophoresis, HPLC, and Scatchard binding isotherm. The data are in accord with protein transport, the main carrier being albumin with two categories of sites. This work suggests that after IV injection of 99mTc-p-butyl-IDA in humans plasma protein binding is one of the limiting factors for the hepatic deposition of the radiopharmaceutical.
Related Publications
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
May 1985,
The International journal of applied radiation and isotopes,
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
January 1982,
Meditsinskaia radiologiia,
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
September 1980,
Kaku igaku. The Japanese journal of nuclear medicine,
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
April 1985,
Nuklearmedizin. Nuclear medicine,
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
May 1980,
Radioisotopes,
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
October 1986,
Nuklearmedizin. Nuclear medicine,
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
August 1980,
Kaku igaku. The Japanese journal of nuclear medicine,
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
March 1980,
Radiology,
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
December 1981,
Radiology,
A Champailler, and
E Gremillet, and
M Decousus, and
A Kassir, and
M Voutay, and
J C Healy
March 1983,
Clinical nuclear medicine,
